Yes intranasal dihexa produces a systemic plasma half life of one to two hours (similar to intraperitoneal), but CNS tissue half life is extended to four to six hours because the peptide is transported directly to the brain along olfactory and trigeminal nerve pathways, bypassing blood-brain barrier penetration and hepatic first-pass metabolism
IGF-1, on the other hand, promotes insulin actions by inhibiting growth hormone
Now, surprising new findings reveal that the medications may have direct protective effects on the liver as well
The manufacturer, Novo Nordisk, states that treatment decisions should be personalized for each individual according to their health condition
Improve sleep posture: Elevate your head while sleeping or try sleeping on your left side to minimize acid reflux
This IgG4-Fc modification reduces the peptides immunologic cytotoxicity by suppressing Fc receptor affinity [2]